Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Marine sponges represent one of the richest sources of natural marine compounds with anticancer potential. Plocabulin (PM060184), a polyketide originally isolated from the sponge , elicits its main anticancer properties binding tubulin, which still represents one of the most important targets for anticancer drugs. Plocabulin showed potent antitumor activity, in both in vitro and in vivo models of different types of cancers, mediated not only by its antitubulin activity, but also by its ability to block endothelial cell migration and invasion. The objective of this review is to offer a description of plocabulin's mechanisms of action, with special emphasis on the antiangiogenic signals and the latest progress on its development as an anticancer agent.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860935 | PMC |
| http://dx.doi.org/10.3390/md21010038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Onnamides and a Novel Analogue, Onnamide G, as Potent Leishmanicidal Agents.
Mar Biotechnol (NY)
September 2025
Faculty of Pharmaceutical Sciences, Tokyo University of Science, Niijuku, Tokyo, Katushika, 125-8585, Japan.
Leishmaniasis is a neglected tropical disease posing significant global health challenges. Given the limited effective treatment options and associated constraints, many patients are unable to complete therapy. In this study, we report the remarkable leishmanicidal activity of onnamides derived from the marine sponge Theonella sp.
View Article and Find Full Text PDFUV Mutagenesis Enhances DHA Biosynthesis in Schizochytrium sp. via Metabolic Reprogramming.
Biotechnol J
September 2025
Key Laboratory of Animal Physiology & Biochemistry, Nanjing Agricultural University, Nanjing, Jiangsu, China.
Schizochytrium sp., a marine alga prized for docosahexaenoic acid (DHA), was subjected to UV mutagenesis to boost industrial yields. The stable mutant UV1-3 achieved 5.
View Article and Find Full Text PDFAnticancer Activity of the Marine-Derived Compound Bryostatin 1: Preclinical and Clinical Evaluation.
Int J Mol Sci
August 2025
Department of Medical Biology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
Bryostatin 1, a natural macrolide isolated from , is a potent modulator of protein kinase C (PKC) isoforms with promising anticancer properties. In numerous in vitro studies, bryostatin 1 has been shown to inhibit tumor cell proliferation and induce differentiation and apoptotic cell death in a wide range of cell lines, including leukemia, lymphoma, glioma, and solid tumors such as ovarian and breast cancer. Its antitumor activity, both as monotherapy and in combination with conventional chemotherapy, has been confirmed in in vivo models, where synergistic effects have been observed, including sensitization of tumor cells to cytostatic agents.
View Article and Find Full Text PDFInvolvement of four alga toxins in the risks of human neurodegenerative diseases: Toxicogenomic data mining and bioinformatics analysis.
J Environ Sci (China)
December 2025
Department of Bioengineering, Harbin Institute of Technology, Weihai 264209, China. Electronic address:
Alga toxins have recently emerged as an environmental risk factor, especially to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. However, the association between the alga toxins β-N-methylamino-L-alanine (BMAA), brevetoxin B, cyanoginosin LR, okadaic acid and neurodegenerative diseases remains inadequately investigated. Therefore, the aim of this study was to elucidate the potential associations.
View Article and Find Full Text PDFNMR-Metabologenomics Coupled with Activity-Picking Inspires Discovery of Samsumycins: a Fast-Mining Strategy for Novel Antibiotics.
Anal Chem
August 2025
Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
The time-consuming and repetitive rediscovery of known molecules has long hindered the efficient identification of novel drug leads from natural sources. Metabologenomics, the synergistic integration of metabolomics and genomics, has emerged as a powerful strategy to circumvent these challenges, enabling targeted discovery of new chemical entities. In this study, we developed a 2D-NMR-based metabologenomics workflow integrated with high-throughput activity screening to rapidly identify a novel family of antibiotic macrolides, samsumycins (-), from the deep-sea sp.
View Article and Find Full Text PDF